Resources
Category
-
Are barriers to eCOA adoption true hurdles?12 December 2019Over recent years, as an industry, we seem… | Read More
-
Switching to digital: why will it help clinical trials stakeholders?19 November 2019
The decline in R&D efficiency is one of… | Read More
-
eCOA Back-up Solutions: Perception vs Reality12 November 2019
Digital solutions have without a doubt improved both… | Read More
-
Press Release // Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector5 November 2019
Proximity will facilitate local and international sponsor access… | Read More
-
How can digital innovation turn clinical trials into a positive patient and site experience?31 October 2019
Digital innovation is increasingly penetrating the healthcare industry… | Read More
-
Kayentis gives back to its community by donating to two local associations8 October 2019
Aware of its responsibility towards the environment, Kayentis… | Read More
-
Kayentis extends its contribution to scientific research in clinical trial endpoint assessment and joins the Critical Path Institute’s ePRO Consortium26 September 2019
Kayentis announces that it has joined the C-Path’s… | Read More
-
eCOA study: Paper back-up and data reliability16 September 2019
eCOA study: the impact of a paper back-up… | Read More
-
Press Release // Kayentis appoints Estelle Haenel as medical director3 September 2019
25-year pharma industry veteran and clinical trials expert… | Read More
-
Inclusion and gender diversity is not a given!26 August 2019
This can only be the result of a… | Read More
-
2018 Employee Satisfaction Survey29 July 2019
The results are in! 2018 was marked by… | Read More
-
The benefits & practicalities of aligning the objectives of an eCOA vendor with those of the study25 July 2019
Any enduring business relationship between a service provider… | Read More
-
Including eCOA in a clinical trial in China16 July 2019
With a large patient pool and growing pharma… | Read More
-
Kayentis supports the 1st personalized immunotherapy treatment approved by both FDA & CHMP9 July 2019Acute Lymphoblastic or Lymphoid Leukemia (ALL) is a… | Read More
-
Six reasons to work at Kayentis11 June 2019
Here are 6 reasons to knock at our… | Read More
-
Kayentis welcomes Estelle Haenel, PharmD, PhD, as Medical Director10 May 2019
Estelle Haenel has joined Kayentis as Medical Director…. | Read More
-
Waste Management Report 201812 March 2019
Kayentis is committed to responsible waste management After… | Read More
-
Implementing Kayentis Spirit in the US, a key challenge for Kayentis team4 March 2019
Interview with Björn Felber – Project Director, Kayentis… | Read More
-
Challenges of back-up solutions in eCOA studies7 February 2019
Why is there a need for a back-up… | Read More
-
Sustainable Mobility Report 201815 November 2018
Moving together towards a better tomorrow At Kayentis,… | Read More
Agenda
